Form 4 for EDIT Editas Medicine, Inc.
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-09 · accession 0001179110-21-008086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-10 | 2021-08-09 | EDIT | ROBERTSON MICHELLE | CFO | M - OptEx | $30.65 | +2,500 | 31.2K | +9% | +$76.6K |
| D | 2021-08-10 | 2021-08-09 | EDIT | ROBERTSON MICHELLE | CFO | S - Sale+OE | $60.00 | -2,500 | 28.7K | -8% | -$150.0K |
| D | 2021-08-10 | 2021-08-09 | EDIT | ROBERTSON MICHELLE | CFO | M - OptEx | $0.00 | -2,500 | 115.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | M | A | 2,500 | $30.65 | 31,235 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-09 | S | D | 2,500 | $60.00 | 28,735 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-09 | M | D | 2,500 | $0.00 | 115,000 | D | $30.65 · — to 2030-01-08 | 2,500 Common Stock | (F2) This option was granted on January 9, 2020 and is scheduled to vest over four years, with 25% of the shares having vested on January 9, 2021, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through January 9, 2024. |